Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients
NCT00646724Phase 2Unknown
- Sponsor
- 900th Hospital of Joint Logistics Support Force of PLA
- Start
- Jan 2008
- Primary completion
- Jan 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mesenchymal stem cells in type 1 diabetes mellitus (T1D), sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Primary endpoints: Exogenous insulin requirement, Hemoglobin A1c and 1 more. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00646724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646724.